Lakeside Holding (LSH) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting is scheduled for June 26, 2025, at the company’s headquarters in Itasca, Illinois, with shareholders of record as of May 13, 2025, eligible to vote.
The only voting matter is the election of five directors to serve until the 2026 annual meeting.
Proxy materials were distributed via full set delivery, and 7,500,000 shares of common stock are outstanding and entitled to vote.
Voting matters and shareholder proposals
Shareholders are asked to elect five directors; no other proposals are on the agenda.
Directors are elected by plurality vote; broker non-votes and abstentions do not affect the outcome.
Shareholder proposals for the 2026 meeting must be received by February 22, 2026, to be considered.
Board of directors and corporate governance
The board consists of five nominees, including three independent directors as determined by Nasdaq rules.
Committees include audit, compensation, and nominating/corporate governance, each composed entirely of independent directors.
The board has adopted a Code of Business Conduct and Ethics, Insider Trading Policy, and Anti-Hedging Policy.
No family relationships exist among directors or executive officers.
Latest events from Lakeside Holding
- Quarterly revenue surged 95% with new pharma sales, but net loss and credit risk remain concerns.LSH
H1 202619 Feb 2026 - Board seeks approval for director elections, capital structure changes, and a key subsidiary sale.LSH
Proxy Filing30 Jan 2026 - Shareholders are asked to approve director elections, capital structure changes, and a key subsidiary sale.LSH
Proxy Filing23 Jan 2026 - Proxy seeks approval for director elections, capital structure changes, and subsidiary sale.LSH
Proxy Filing12 Jan 2026 - Shareholders to vote on major capital, governance, and digital asset strategy changes.LSH
Proxy Filing2 Dec 2025 - IPO offers 1,250,000 shares plus over-allotment, led by Benchmark and Axiom, Nasdaq listing planned.LSH
Registration Filing30 Nov 2025 - Amendment updates IPO exhibits, outlines $1.4M expenses, and details management and indemnification.LSH
Registration Filing30 Nov 2025 - Offering up to 7.97M shares via convertible notes and warrants, with strong Asia-U.S. logistics focus.LSH
Registration Filing29 Nov 2025 - Registering 7.97M shares for resale, the company faces growth, risk, and compliance challenges.LSH
Registration Filing29 Nov 2025